Read publication

In this issue:

  • The "Cura Italia" Decree Law comes into force
  • The AIFA publishes guidelines on clinical trials to be conducted during the coronavirus emergency
  • Coronavirus emergency: the Italian Central Purchasing Entity launches public procurement emergency procedures for supplies related to the health crisis
  • EMA: developers of medicines or vaccines are admitted to benefit from free scientific advice
  • The Italian Medicines Agency establishes a Coronavirus Crisis Unit
  • Covid-19: The Italian Antitrust Authority suspends the marketing of an anti-viral drug and provides the shutdown of the website used for its promotion
  • Covid-19, Italy is among the countries that will test Remdesivir anti-viral
Explore More Insight